A detailed history of Optiver Holding B.V. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Optiver Holding B.V. holds 40 shares of OCUL stock, worth $390. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40
Previous 1,325 96.98%
Holding current value
$390
Previous $9,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.45 - $9.23 $8,288 - $11,860
-1,285 Reduced 96.98%
40 $0
Q2 2024

Aug 14, 2024

BUY
$4.2 - $8.69 $5,565 - $11,514
1,325 New
1,325 $9,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $750M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Optiver Holding B.V. Portfolio

Follow Optiver Holding B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

News

Stay updated on Optiver Holding B.V. with notifications on news.